Remove 2022 Remove Law & Regulation Remove Safety
article thumbnail

How the Ukrainian clinical trial industry is overcoming disruption

Pharmaceutical Technology

Clinical trials were thrown into turmoil on the morning of 24 February 2022, along with every aspect of life in Ukraine. Research recommencing has been accelerated by ingenuity from Ukrainian policymakers and businesses in two key areas: law and logistics. In July, approximately a third of companies had paused a trial in the country.

article thumbnail

New quality requirements for tobacco products

European Pharmaceutical Review

He is currently a CMC consultant with an interest in impurities and safety‑based limits. Assessment report Procedure under Article 5(3) of Regulation EC (No) 726/2004 Nitrosamine impurities in human medicinal products Procedure number: EMEA/H/A-5(3)/1490 EMA/369136/2020 Committee for Medicinal Products for Human Use (CHMP).